Weight Management

VK2735

Viking VK2735 · VK-2735

Viking Therapeutics investigational dual GLP-1/GIP receptor agonist (VK2735), studied in subcutaneous and oral obesity programs. Not tirzepatide. Not a gray-market twincretin with a forged COA.

Not FDA-approved - research chemical

Reviewed by CalcMyPeptide Editorial Team

·Last updated: September 2026·Evidence: Emerging

Typical research dose

Investigational - sponsor protocol only

Frequency

Weekly-class in Viking program (not a cake)

Half-life

Weekly-class program (sponsor PK)

Common vials

N/A (oral)

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

Metabolic / weight6.5/10
Dual GLP-1/GIP obesity program. Haircut: not tirzepatide, not a finished pen, not a research cake.

Compound card

Sequence: Dual GLP-1/GIP agonist (Viking VK2735)
Class: Investigational dual incretin agonist (Viking Therapeutics)
Formula: Dual GLP-1/GIP peptide analog (proprietary)
Status: Not FDA-approved · research use

How it works

VK2735 is Viking Therapeutics’ investigational dual GLP-1/GIP receptor agonist, studied in subcutaneous and oral obesity programs. Mechanism class overlaps tirzepatide’s twincretin idea; the molecule, manufacturing, and trial supply do not.

Source: Viking Therapeutics clinical program disclosures; not a finished US label

Research Use Cases

✓Obesity pipeline literacy: Moderate
✓Research reconstitution: Low

Dosing

Phase	Dose	Frequency	Notes
Human care	Sponsor protocol only	Weekly-class in program	Not Zepbound titration folklore paste.
Research-chem SKU	Do not invent	n/a	Skip the calculator until identity is real.

Administration

Route / form

SC or oral under clinical protocol (program-specific)

Timing

Program-defined

Empty stomach?

No - Food timing is not critical.

Timeline

Trial programs

Weight endpoints are sponsor-owned.

Who it is for

Obesity pipeline literacy

Moderate

Know it exists; do not DIY it.

Research reconstitution

Low

Wrong tool.

Safety & Considerations

Investigational incretin-class GI risk. Unverified cakes are a separate problem. Not pregnancy-safe by default.

Regulatory & Legal Status

FDA Status (US)

Research Only

WADA Status (2026)

Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.